These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Antitumor and toxicity properties of some peptides of 1-aminocyclopentanecarboxylic acid (NSC-1026). ROBERTS M; SHANKMAN S Tex Rep Biol Med; 1963; 21():277-83. PubMed ID: 13974316 [No Abstract] [Full Text] [Related]
44. Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin. KRISS JP; BIERMAN HR; THOMAS SF; NEWELL RR Radiology; 1955 Aug; 65(2):241-9. PubMed ID: 13245970 [No Abstract] [Full Text] [Related]
45. THE DETECTION OF RADIOACTIVE L-AMINOCYCLOPENTANECARBOXYLIC ACID IN TISSUES. ROBERTS ME; CIOFALO L; MARTIN L Stain Technol; 1964 Jan; 39():47-50. PubMed ID: 14106466 [No Abstract] [Full Text] [Related]
47. The use of M and B 938 in myelomatosis. WARD HW J Fac Radiol; 1958 Oct; 9(4):221-2. PubMed ID: 24544992 [No Abstract] [Full Text] [Related]
48. [Treatment of malignant systemic diseases]. VIDEBAEK A Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805 [No Abstract] [Full Text] [Related]
49. [Experiences with high dosage prednisone therapy and its side-effects in hemoblastosis, especially in plasmocytoma]. WITTEKIND D; SESSNER HH Dtsch Arch Klin Med; 1960; 206():636-62. PubMed ID: 13786084 [No Abstract] [Full Text] [Related]
50. Jaundice during treatment of myelomatosis with M & B 938. DENMAN AM; WARD HW Br Med J; 1960 Feb; 1(5171):482. PubMed ID: 13815928 [No Abstract] [Full Text] [Related]
51. Chemotherapeutic control of multiple myeloma. SAMPEY JR J S C Med Assoc; 1959 May; 55(5):183-4. PubMed ID: 13655275 [No Abstract] [Full Text] [Related]
52. Urethane-induced hepatic failure in man. WEISS DL; DE LOS SANTOS R Am J Med; 1960 Mar; 28():476-81. PubMed ID: 13843702 [No Abstract] [Full Text] [Related]
53. On the effect of corticotropin (ACTH) on myelomatosis with special reference to the bone marrow and the serum proteins. Effersøe P; Gormsen H; Harboe N; Nielsen SE; Videbaek AA Acta Med Scand; 1952 May; 143(1):63-82. PubMed ID: 12976012 [No Abstract] [Full Text] [Related]
54. The use of combination 5-fluorouracil and supervoltage irradiation therapy in advanced carcinoma of the urinary bladder--a preliminary report. WOODRUFF MW; MURPHY WT; HODSON JM Cancer Chemother Rep; 1962 Aug; 21():123-7. PubMed ID: 14008235 [No Abstract] [Full Text] [Related]
55. [Extramedullary plasmocytoma of the vulva]. BERGER J Hautarzt; 1956 Apr; 7(4):168-71. PubMed ID: 13318614 [No Abstract] [Full Text] [Related]
56. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)]. HEILMANN D Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130 [No Abstract] [Full Text] [Related]
57. An experiment in the use of sarcolysin in myelomatosis. ALEKSEYEV GA; PETROV KI Probl Gematol Pereliv Krovi; 1961; 6():801-9. PubMed ID: 14036660 [No Abstract] [Full Text] [Related]
58. [Treatment of multiple myeloma with radioactive phosphorus]. NIKONOVA ON Vestn Rentgenol Radiol; 1955; (3):82-4. PubMed ID: 13256982 [No Abstract] [Full Text] [Related]
59. [Treatment of myelomatosis with sarcolysin associated with ACTH and steroid hormones]. CHIGIRINSKII AN Vopr Onkol; 1961; 7(7)():63-9. PubMed ID: 13693075 [No Abstract] [Full Text] [Related]
60. Multiple myeloma--an update on diagnosis and treatment. Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]